Health · 31 July 2026

How does one cell batch treat hundreds of patients?

Unsplash / Lucas Vasques

Engineered donor immune cells, mass-produced in one batch, supply hundreds of doses instead of one bespoke treatment per patient. Zelluna's ZI-MA4-1 therapy gave Tracy Tomlinson, 58, of Chadderton three infusions at Manchester's Christie NHS Foundation Trust after her stage 3C ovarian cancer returned. She had endured 48 chemotherapy rounds already, and only around 15% of women survive advanced ovarian cancer five years.

By BriefTea Editorial · 31 July 2026 at 10:57

Reported by Sky News · How we write briefs

Get the app

More briefs

WorldUS brain fungus cases quadruple in two years Health82% of therapists say normal emotions are now 'illnesses' HealthScience Corp implants PRIMA vision chip in first Stargardt patient, who reads a word HealthTwo HRT patch brands, Estradot and FemSeven Conti, are in short supply WorldIndonesia Tests Dry Ice to Clear Toxic Wildfire Haze PoliticsMore Seven-Year-Olds Than 50-Year-Olds Get Disability Benefits More health stories → Browse all stories →